One such change, often less spoken about, is the enlargement of the prostate gland. This condition, known as Benign Prostatic Hyperplasia (BPH), is extremely common, especially in men above 50 years ...

India, March 17 -- Latest study shows a serious link between emergency room wait times and patient survival. One in ten ...

Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found.

One in ten emergency patients with visible blood in their urine dies within three months of presenting at hospital emergency ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on costly brain scans or invasive spinal fluid tests to identify the ...

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...